Raytchev et al.
JOCNote
to room temperature, and distilled water (250 mL) was added.
The aqueous mixture was then extracted with ethyl acetate (4 ꢀ
150 mL). The combined organic layers were washed with
distilled water (2 ꢀ 150 mL), dried over Na2SO4, and concen-
trated under vacuum. The crude product was dissolved in
CH2Cl2 and precipitated with diethyl ether to give pure 11 as a
white powder (9.9 g, 58%). ESI-MS m/z obsd 1321.6171 ([M þ
Na]þ, calcd 1321.6148 for C72H90N4O18Na). 1H NMR (CDCl3,
297 K, 497.80 MHz): δ 7.41 (t, 3H, 3J = 5.52 Hz, NHCdO), 7.10
(d, 6H, 3J = 8.62 Hz, ArH), 6.86-6.90 (m, 9H, ArH), 6.83 (d,
6H, 3J = 8.66 Hz, ArH), 4.70 (d, 3H, 2J = 11.71 Hz, ArCH2O),
4.66 (t, 3H, 3J = 3.64 Hz, OTHP), 4.42 (d, 3H, 2J = 11.71 Hz,
ArCH2O), 4.23-4.34 (m, 18H, ArCH2N ; O(CH2)2O), 3.91 (m,
3H, OTHP), 3.82 (s, 9H, ArOMe), 3.53 (m, 3H, OTHP), 3.25 (s,
6H, N(CH2)3) 1.47-1.89 (m, 18H, OTHP). 13C NMR (CDCl3,
297 K, 125.17 MHz): δ 170.1 (NHCdO), 158.0 (CArO), 149.6
(CArO), 147.5 (CArO),131.8 (CAr), 130.4 (CAr), 129.0 (CAr),
120.5 (CAr), 114.8 (CAr), 114.0 (CAr), 112.0 (CAr), 97.6 (OCO),
68.7 (CH2O), 67.8 (CH2O), 66.5 (CH2O), 62.3 (CH2O), 60.2
(NCH2), 55.9 (OMe), 42.8 (NCH2), 30.6, 25.4, 19.5 (OTHP).
Synthesis of Tren-hemicryptophane 4. Compound 3 (310 mg)
was dissolved under vigorous stirring in a 2 M solution of
H3B SMe2 in THF (15 mL). The solution was stirred for 1 week
3
at 65 °C. After the mixture cooled to room temperature,
methanol (6 mL) and aqueous 1 M HCl (1 mL) were successively
added dropwise. The solution was then heated at 40 °C for 1 day.
The solvents were removed under vacuum, and the residue was
dissolved in chloroform (10 mL). Methanol (7 mL) and aqueous
1 M HCl (1 mL) were then added, and the mixture was stirred for
2 days at 60 °C. The solvents were removed, and the residue
was dissolved in chloroform (50 mL) and aqueous 1 M NaOH
(50 mL). The organic layer was separated, and the aqueous
phase was extracted with chloroform (3 ꢀ 40 mL).The combined
organic layers were dried over Na2SO4, and the solvent was
removed under vacuum. The crude product was purified by
column chromatography on silica gel using a 90:10:2 mixture of
CH2Cl2, methanol, and triethylamine to give 4 as a white solid
(89 mg, 30%). Crystals suitable for X-ray crystallography were
obtained by allowing pentane to slowly diffuse in a concentrated
solution of 4 in CH2Cl2 at 5 °C. ESI-MS m/z obsd 951.4916
([M þ H]þ, calcd 951.4908 for C57H67N4O9). 1H NMR (CDCl3,
297 K, 497.80MHz): δ 7.01 (s, 3H, ArH), 6.91(br, 6H, ArH), 6.82
(s, 3H, ArH), 6.48 (d, 6H, 3J = 7.56 Hz, ArH), 4.75 (d, 3H, 2J =
13.63 Hz, Ha), 4.14-4.42 (m, 12H, O(CH2)2O), 3.65 (s, 9H,
OMe), 3.54 (d, 3H, 2J = 13.63 Hz, He), 3.43-3.54 (br, 6H,
ArCH2N), 2.48-2.70 (br, 12H, N(CH2)2N). 13C NMR (CDCl3,
297 K, 125.17 MHz): δ 157.4 (NHCdO), 148.3 (CArO), 146.4
(CArO), 133.0 (CAr), 132.9 (CAr), 131.7 (CAr), 129.1 (CAr), 116.8
(CAr), 114.7 (CAr), 113.5 (CAr), 67.7 (OCH2), 67.6 (OCH2), 55.9
(OMe), 55.6 (NCH2), 53.0 (NCH2), 47.0 (NCH2), 36.5 (ArCAr).
Anal. Calcd for C72H90N4O18 CH2Cl2: C, 63.33; H, 6.70; N,
3
4.05. Found: C, 63.65; H, 6.68; N, 4.21.
Synthesis of Triamide-hemicryptophane 3. Precursor 11 (2.50
g, 1.93 mmol) was dissolved in formic acid (2.5 L). The mixture
was stirred for 1 day at room temperature, and then the formic
acid was removed under vacuum. The brown residue was
dissolved in chloroform (100 mL), and aqueous K2CO3 (10%,
50 mL) was added. The organic layer was separated, and the
aqueous phase was extracted with chloroform (2 ꢀ 100 mL). The
combined organic layers were dried with Na2SO4, and then the
organic solvent was removed under vacuum. The crude product
was purified by column chromatography on silica gel using a
15:3 mixture of chloroform and methanol as eluent to give 3
(575 mg, 30%) as a white powder. Crystallization from CH2Cl2
gave suitable material for X-ray crystallography analysis.
ESI-MS m/z obsd 1015.4093 ([M þ Na]þ, calcd 1015.4105 for
X-ray Crystallography. 3 CH2Cl2: C58H62Cl2N4O12, Mw
3
˚
1078.05 monoclinic P21/n, a = 10.997(5) A, b = 18.282(5) A,
˚
3
˚
˚
c = 28.996(5) A, β = 95.320(5)°, V = 5804(3) A , Dc = 1.230 g
cm-3, Z = 4, μ = 0.17 mm-1, R1 = 0.136, wR2 = 0.144 for 3218
reflections with I > 2σ(I). 4 Pentane: C62H78N4O9, Mw 1023.32
3
˚
˚
˚
trigonal R-3, a = 16.61(2) A, b = 16.61(8) A, c = 37.24(1) A, V =
1
3
8897(3) A , Dc =1.148gcm-3, Z=2, μ=0.08mm-1, R1 = 0.139,
˚
C57H60N4O12Na). H NMR (CDCl3, 297 K, 497.80 MHz): δ
7.04 (s, 3H, ArH), 6.82 (s, 3H, ArH), 6.75 (l, 3H, NHCdO),
wR2 = 0.171 for 1469 reflections with I > 2σ(I). Details on data
collections and refinements are reported in Supporting Information.
3
6.655 (d, 6H, 3J = 8.56 Hz, ArH), 6.35 (d, 6H, J = 8.56 Hz,
ArH), 4.77 (d, 3H, 2J = 13.69 Hz, Ha), 4.49-4.55 (m, 3H,
O(CH2)2O), 4.31-4.37 (m, 3H, O(CH2)2O), 4.20-4.28 (m, 6H,
O(CH2)2O; ArCH2N), 4.13-4.19 (m, 3H, O(CH2)2O), 3.70
Acknowledgment. The authors thank Dr. Erwann Jeanneau
ꢀ
(Centre de Diffractometrie Henri Longchambon, University of
Lyon) for X-ray assistance and facilities.
2
(dd, 3H, ArCH2N), 3.64 (s, 9H, ArOMe), 3.55 (d, 3H, J =
13.69 Hz, He), 3.18 (d, 3H, 2J = 16.49 Hz, N(CH2)3), 3.12 (d,
3H, 2J = 16.49 Hz, N(CH2)3). 13C NMR (CDCl3, 297 K, 125.17
MHz): δ 169.5 (NHCdO), 157.7 (CArO), 148.3 (CArO), 146.3
(CArO), 132.9 (CAr), 131.8 (CAr), 130.35 (CAr), 128.76 (CAr),
116.61 (CAr), 114.92 (CAr), 113.6 (CAr), 67.9 (OCH2), 67.3 (OCH2),
60.9 (NCH2), 55.8 (OMe), 42.7 (NCH2), 36.5 (ArCAr). Anal.
Supporting Information Available: General experimental
methods for compounds 3, 4, and 9-11; 1H and 13C NMR
spectra for all new compounds; crystallographic information
files in CIF format for 3 CH2Cl2 (CCDC 758472) and
4 pentane (CCDC 758471). This material is available free of
3
Calcd for C57H60N4O12 2CH2Cl2: C, 60.93; H, 5.55; N, 4.82.
3
3
Found: C, 60.63; H, 5.58; N, 5.01.
2102 J. Org. Chem. Vol. 75, No. 6, 2010